Phlexglobal provides a global consolidated eTMF solution for Bayer
Phlexglobal, pioneers in the specialist provision of electronic Trial Master File (eTMF) technology and TMF services to the life sciences industry announces the success of its market leading eTMF, PhlexEview, as the eTMF solution for the Pharmaceuticals Division of Bayer.
One year on from the rapid 9 week period implementation in 2015, a comprehensive solution has been deployed across the majority of recent Bayer clinical trials, consolidating documents from partners and vendors, and used by thousands of worldwide users. PhlexEview implementation included fully managed new study and user set up; a common TMF structure based on the TMF reference model version 3; multiple input and output streams, and centralized reporting and oversight.
Various project milestones have since been successfully achieved. The next step will be the adoption of PhlexEview version 4. This version is set to further improve the worldwide eTMF maturity program, which will see the provision of document approval workflows; CRO use, and integration with internal Bayer systems for CTMS, EDC, IVRS, contracts and regulatory submissions.
Phlexglobal has also introduced recommendations on best practice and provided expert resource to provide quarterly ongoing TMF QC services.
“We are excited to be a partner of Bayer to provide PhlexEview as their full TMF management solution. PhlexEview is providing a global eTMF in one common TMF structure, with CRO oversight metrics, and so much more,” said Karen Roy, senior vice president, client solutions.
PhlexEview is the leading regulatory compliant and hosted solution for managing, organizing, and displaying TMF documents. PhlexEview enables users to enhance their work practices while increasing their efficiency through the use of specialized software.
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services. They offer a unique combination of clinical trial knowledge, document management skills, regulatory understanding and technical expertise to deliver a range of flexible, targeted solutions to meet business needs.
More information can be found at http://www.phlexglobal.com
Gillian Gittens, head of marketing
Tel: +44(0)1494 720420
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum